FindTrial
Sign In

The study of Parkinson's disease imaging biomarkers based on MR with high resolution and multi mode

The study of Parkinson's disease imaging biomarkers based on MR with high resolution and multi mode

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DRD-16008778
Enrollment
Unknown
Registered
2016-07-04
Start date
2016-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson`s Disease

Interventions

Gold Standard:
Index test:

Sponsors

Xiangyang Hospital, Hubei University of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: PD patients diagnosed according to the "MDS Clinical Diagnostic Criteria for Parkinson's disease". MSA and PSP patients diagnosed according to the reference. All subjects were signed a patient empowerment, allowing the use and disclosure of personal health information (or informed consent).

Exclusion criteria

Exclusion criteria: Patients with secondary Parkinson's syndrome(vascular, traumatic, poisoning, etc.)

Design outcomes

Primary

MeasureTime frame
Dorsolateral Nigral Hyperintensity;—

Countries

China

Contacts

Public ContactPuqing Wang

Xiangyang Hospital, Hubei University of Medicine

wpq20110328@qq.com+86 15072288918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026